Harmony Biosciences
HRMY
#5088
Rank
โ‚น167.00 B
Marketcap
โ‚น2,885
Share price
-1.12%
Change (1 day)
-0.79%
Change (1 year)

Revenue for Harmony Biosciences (HRMY)

Revenue in 2026 (TTM): โ‚น80.47 Billion

According to Harmony Biosciences's latest financial reports the company's current revenue (TTM ) is โ‚น86.02 Billion. In 2025 the company made a revenue of โ‚น77.96 Billion an increase over the revenue in the year 2024 that were of โ‚น61.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Harmony Biosciences from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น80.47 B3.23%
2025 โ‚น77.96 B27.15%
2024 โ‚น61.31 B26.55%
2023 โ‚น48.45 B33.73%
2022 โ‚น36.23 B59.37%
2021 โ‚น22.73 B94.6%
2020 โ‚น11.68 B2632.71%
2019 โ‚น0.42 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น61.43 B-28.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.62 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA